Clinical evidence further supports this duality: serum SELENOP levels increase during prediabetes but decline as T2DM progresses, suggesting compensatory overexpression preceding selenoprotein exhaustion (21). This evidence concerns the gene SELENOP and type 2 diabetes mellitus.